Inscrição na biblioteca: Guest
Critical Reviews™ in Immunology

Publicou 6 edições por ano

ISSN Imprimir: 1040-8401

ISSN On-line: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Interleukin 35−Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases

Volume 35, Edição 1, 2015, pp. 49-57
DOI: 10.1615/CritRevImmunol.2015012558
Get accessGet access

RESUMO

Neuroinflammation contributes to neuronal deficits in neurodegenerative CNS (central nervous system) autoimmune diseases, such as multiple sclerosis and uveitis. The major goal of most treatment modalities for CNS autoimmune diseases is to limit inflammatory responses in the CNS; immune-suppressive drugs are the therapy of choice. However, lifelong immunosuppression increases the occurrence of infections, nephrotoxicity, malignancies, cataractogenesis, and glaucoma, which can greatly impair quality of life for the patient. Biologics that target pathogenic T cells is an alternative approach that is gaining wide acceptance as indicated by the popularity of a variety of Food and Drug Administration (FDA)-approved anti-inflammatory compounds and humanized antibodies such as Zenapax, Etanercept, Remicade, anti-ICAM, rapamycin, or tacrolimus. B cells are also potential therapeutic targets because they provide costimulatory signals that activate pathogenic T cells and secrete cytokines that promote autoimmune pathology. B cells also produce autoreactive antibodies implicated in several organ-specific and systemic autoimmune diseases including lupus erythematosus, Graves' disease, and Hashimoto's thyroiditis. On the other hand, recent studies have led to the discovery of several regulatory B-cell (Breg) populations that suppress immune responses and autoimmune diseases. In this review, we present a brief overview of Breg phenotypes and in particular, the newly discovered IL35-producing regulatory B cell (i35-Breg). We discuss the critical roles played by i35-Bregs in regulating autoimmune diseases and the potential use of adoptive Breg therapy in CNS autoimmune diseases.

CITADO POR
  1. Lei Hong, Schmidt-Bleek Katharina, Dienelt Anke, Reinke Petra, Volk Hans-Dieter, Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners, Frontiers in Pharmacology, 6, 2015. Crossref

  2. Egwuagu Charles E., Yu Cheng-Rong, Sun Lin, Wang Renxi, Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases, Cytokine & Growth Factor Reviews, 26, 5, 2015. Crossref

  3. Han Jinming, Sun Li, Fan Xueli, Wang Zhongkun, Cheng Yun, Zhu Jie, Jin Tao, Role of regulatory b cells in neuroimmunologic disorders, Journal of Neuroscience Research, 94, 8, 2016. Crossref

  4. Han Jinming, Sun Li, Wang Zhongkun, Fan Xueli, Wang Lifang, Song Yang-yang, Zhu Jie, Jin Tao, Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders, Neurological Sciences, 38, 7, 2017. Crossref

  5. Choi Jin Kyeong, Dambuza Ivy M., He Chang, Yu Cheng-Rong, Uche Anita N., Mattapallil Mary J., Caspi Rachel R., Egwuagu Charles E., IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis, Frontiers in Immunology, 8, 2017. Crossref

  6. Dambuza Ivy M., He Chang, Choi Jin Kyeong, Yu Cheng-Rong, Wang Renxi, Mattapallil Mary J., Wingfield Paul T., Caspi Rachel R., Egwuagu Charles E., IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease, Nature Communications, 8, 1, 2017. Crossref

  7. Ellis Jason, Braley-Mullen Helen, Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases, Journal of Clinical Medicine, 6, 2, 2017. Crossref

  8. Hofmann Katharina, Clauder Ann-Katrin, Manz Rudolf Armin, Targeting B Cells and Plasma Cells in Autoimmune Diseases, Frontiers in Immunology, 9, 2018. Crossref

  9. Gery Igal, Caspi Rachel R., Tolerance Induction in Relation to the Eye, Frontiers in Immunology, 9, 2018. Crossref

  10. Seifert Hilary A., Vandenbark Arthur A., Offner Halina, Regulatory B cells in experimental stroke, Immunology, 154, 2, 2018. Crossref

  11. Al-Badri Ghaith, Castorina Alessandro, Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis, Journal of Functional Morphology and Kinesiology, 3, 1, 2018. Crossref

  12. Thompson Aiysha, Orr Selinda J., Emerging IL-12 family cytokines in the fight against fungal infections, Cytokine, 111, 2018. Crossref

  13. Vasileiadis Georgios K., Dardiotis Efthymios, Mavropoulos Athanasios, Tsouris Zisis, Tsimourtou Vana, Bogdanos Dimitrios P., Sakkas Lazaros I., Hadjigeorgiou Georgios M., Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?, Autoimmunity Highlights, 9, 1, 2018. Crossref

  14. Rubin Samuel J. S., Bloom Michelle S., Robinson William H., B cell checkpoints in autoimmune rheumatic diseases, Nature Reviews Rheumatology, 15, 5, 2019. Crossref

  15. Wildner Gerhild, Diedrichs-Möhring Maria, Resolution of uveitis, Seminars in Immunopathology, 41, 6, 2019. Crossref

  16. Guram Kripa, Kim Sangwoo S., Wu Victoria, Sanders P. Dominick, Patel Sandip, Schoenberger Stephen P., Cohen Ezra E. W., Chen Si-Yi, Sharabi Andrew B., A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy, Frontiers in Immunology, 10, 2019. Crossref

  17. Das Shipra, Bar-Sagi Dafna, BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis, Oncogene, 38, 17, 2019. Crossref

  18. Morris Gerwyn, Puri Basant K., Olive Lisa, Carvalho Andre F., Berk Michael, Maes Michael, Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: Association with inflammation, oxidative and nitrosative stress and autoimmune responses, Pharmacological Research, 148, 2019. Crossref

  19. Ma Siyuan, Satitsuksanoa Pattraporn, Jansen Kirstin, Cevhertas Lacin, Veen Willem, Akdis Mübeccel, B regulatory cells in allergy, Immunological Reviews, 299, 1, 2021. Crossref

  20. Aziz Monowar, Brenner Max, Wang Ping, Therapeutic Potential of B-1a Cells in COVID-19, Shock, 54, 5, 2020. Crossref

  21. Jansen Kirstin, Cevhertas Lacin, Ma Siyuan, Satitsuksanoa Pattraporn, Akdis Mübeccel, van de Veen Willem, O'Hehir Robyn, Regulatory B cells, A to Z, Allergy, 76, 9, 2021. Crossref

  22. Gangaputra Sapna, Chaigne-Delalande Benjamin, Gery Igal, Sen H. Nida, Ocular Disease, in The Autoimmune Diseases, 2020. Crossref

  23. Khalil Mohamed, Wang Dandan, Hashemi Elaheh, Terhune Scott S., Malarkannan Subramaniam, Implications of a ‘Third Signal’ in NK Cells, Cells, 10, 8, 2021. Crossref

  24. Mirlekar Bhalchandra, Michaud Daniel, Pylayeva-Gupta Yuliya, IL-35 Detection in B Cells at the mRNA and Protein Level, in Regulatory B Cells, 2270, 2021. Crossref

  25. Wu Fengping, Gao Jinfang, Kang Jie, Wang Xuexue, Niu Qing, Liu Jiaxi, Zhang Liyun, B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects, Frontiers in Immunology, 12, 2021. Crossref

  26. Liu YaYun, Luo Ying, Zhu Tong, Jiang Meng, Tian ZhaoFeng, Tang GuSheng, Liang XueSong, Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B, Frontiers in Immunology, 12, 2021. Crossref

  27. Alenazy Maha Fahad, Saheb Sharif-Askari Fatemeh, Omair Mohammed A., El-Wetidy Mohammad S., Omair Maha A., Mitwalli Hussam, Al-Muhsen Saleh, Al-Masri Abeer, Hamid Qutayba, Halwani Rabih, Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance, Scientific Reports, 11, 1, 2021. Crossref

  28. Grubczak Kamil, Starosz Aleksandra, Stożek Karolina, Bossowski Filip, Moniuszko Marcin, Bossowski Artur, Regulatory B Cells Involvement in Autoimmune Phenomena Occurring in Pediatric Graves’ Disease Patients, International Journal of Molecular Sciences, 22, 20, 2021. Crossref

  29. Auclair Héloïse, Ouk-Martin Catherine, Roland Lilian, Santa Pauline, Al Mohamad Hazar, Faumont Nathalie, Feuillard Jean, Jayat-Vignoles Chantal, EBV Latency III–Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1–Dependent Manner, The Journal of Immunology, 203, 6, 2019. Crossref

  30. Xiao Tao, Qu Hongtao, Zeng Zhiqing, Li Chuanghua, Wan Juan, Interleukin-35 from Interleukin-4-Stimulated Macrophages Alleviates Oxygen Glucose Deprivation/Re-oxygenation-Induced Neuronal Cell Death via the Wnt/β-Catenin Signaling Pathway, Neurotoxicity Research, 40, 2, 2022. Crossref

  31. Seals Malik R., Moran Monica M., Leavenworth Jonathan D., Leavenworth Jianmei W., Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis, Frontiers in Immunology, 13, 2022. Crossref

  32. Tedder Thomas F., Introduction: Regulatory B Cell Special Issue—making all the pieces fit, International Immunology, 27, 10, 2015. Crossref

  33. Zou Juan, Zeng Zijun, Xie Wen, Zeng Zhimei, Immunotherapy with regulatory T and B cells in periodontitis, International Immunopharmacology, 109, 2022. Crossref

  34. Rastogi Ichwaku, Jeon Donghwan, Moseman Jena E., Muralidhar Anusha, Potluri Hemanth K., McNeel Douglas G., Role of B cells as antigen presenting cells, Frontiers in Immunology, 13, 2022. Crossref

  35. Thurau Stephan, Deuter Christoph M. E., Heiligenhaus Arnd, Pleyer Uwe, Van Calster Joachim, Barisani-Asenbauer Talin, Obermayr Franz, Sperl Stefan, Seda-Zehetner Romana, Wildner Gerhild, A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial, Frontiers in Medicine, 9, 2022. Crossref

  36. Xiong Hui, Tang Zengqi, Xu Ying, Shi Zhenrui, Guo Zhixuan, Liu Xiuting, Tan Guozhen, Ai Xuechen, Guo Qing, CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients, Advances in Rheumatology, 62, 1, 2022. Crossref

Próximos artigos

Identification of key chondrocyte apoptosis-related genes in osteoarthritis based on weighted gene co-expression network analysis and experimental verification Wei Wang, Junyi Hong, Tianyi Cao, Fusheng Ye, Junwei Gao, Shumei Qin Anoikis and Mitophagy-Related Gene Signature for Predicting the Survival and Tumor Cell Progression in Colon Cancer Jian Shen, Minzhe Li Exploring the mechanism of Isoforskolin against asthma based on network pharmacology and experimental verification Yan Fang, Shibo Sun, Chuang Xiao, Min Li, Yuanyuan Zheng, Anju Zu, Zhuang Luo Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain